title: Pitfalls in the diagnosis and management of Cushing's syndrome.
abstract: Despite many recent advances, the management of patients with Cushing's disease continues to be challenging. Cushing's syndrome is a complex metabolic disorder that is a result of excess glucocorticoids. Excluding the exogenous causes, adrenocorticotropic hormone-secreting pituitary adenomas account for nearly 70% of all cases of Cushing's syndrome. The suspicion, diagnosis, and differential diagnosis require a logical systematic approach with attention paid to key details at each investigational step. A diagnosis of endogenous Cushing's syndrome is usually suspected in patients with clinical symptoms and confirmed by using multiple biochemical tests. Each of the biochemical tests used to establish the diagnosis has limitations that need to be considered for proper interpretation. Although some tests determine the total daily urinary excretion of cortisol, many others rely on measurements of serum cortisol at baseline and after stimulation (e.g., after corticotropin-releasing hormone) or suppression (e.g., dexamethasone) with agents that influence the hypothalamic-pituitary-adrenal axis. Other tests (e.g., measurements of late-night salivary cortisol concentration) rely on alterations in the diurnal rhythm of cortisol secretion. Because more than 90% of the cortisol in the circulation is protein bound, any alteration in the binding proteins (transcortin and albumin) will automatically influence the measured level and confound the interpretation of stimulation and suppression data, which are the basis for establishing the diagnosis of Cushing's syndrome. Although measuring late-night salivary cortisol seems to be an excellent initial test for hypercortisolism, it may be confounded by poor sampling methods and contamination. Measurements of 24-hour urinary free-cortisol excretion could be misleading in the presence of some pathological and physiological conditions. Dexamethasone suppression tests can be affected by illnesses that alter the absorption of the drug (e.g., malabsorption, celiac disease) and by the concurrent use of medications that interfere with its metabolism (e.g., inducers and inhibitors of the P450 enzyme system). In this review, the authors aim to review the pitfalls commonly encountered in the workup of patients suspected to have hypercortisolism. The optimal diagnosis and therapy for patients with Cushing's disease require the thorough and close coordination and involvement of all members of the management team.
authors: Division of Endocrinology and the Neurological Institute, University Hospitals/Case Medical Center, Case Western Reserve University, Cleveland, Ohio.
authors: Vivek
authors: V
authors: Bansal
authors: Nadine
authors: N
authors: El Asmar
authors: Warren R
authors: WR
authors: Selman
authors: Baha M
authors: BM
authors: Arafah
mesh_terms: D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D003480:Cushing Syndrome / Q000175:diagnosis* / Q000378:metabolism*; D003937:Diagnosis, Differential; D019468:Disease Management; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis / Q000378:metabolism; D012463:Saliva / Q000737:chemistry / Q000378:metabolism
chemical_list: D015415:Biomarkers; D006854:Hydrocortisone
keywords: ACTH = adrenocorticotropic hormone; CRH = corticotropin-releasing hormone; Cushing's syndrome; HPA = hypothalamic-pituitary-adrenal; HPLC = high-pressure liquid chromatography; IPSS = inferior petrosal sinus sampling; diagnostic pitfalls; hypercortisolism